Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_assertion type Assertion NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_head.
- NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_assertion description "[Analyses of 29 5q- AML/myelodysplastic syndrome (MDS) samples revealed marked decreases in expression of alpha-catenin, compared to non-5q- MDS samples (6.6+/-9-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_provenance.
- NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_assertion evidence source_evidence_literature NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_provenance.
- NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_assertion SIO_000772 17330099 NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_provenance.
- NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_assertion wasDerivedFrom befree-20140225 NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_provenance.
- NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_assertion wasGeneratedBy ECO_0000203 NP687583.RAPjZRTqr4o5FQriN21xkpkGs207F-_ZDGUcr4jZmQX7Y130_provenance.